Menopause Infrastructure Layer
The diagnostics, therapeutics, clinics, employer benefits, and media layer forming around the menopause transition.
Market opportunity$15.4B (2021) → $24.4B (2030)Global menopause market — driven by hormone therapy, OTC products, virtual clinics, and employer benefits.Grand View Research — Menopause Market Size Report ↗
Menopause is transitioning from invisible to a multi-billion-dollar category with integrated care models — diagnostics, virtual hormone-therapy clinics, OTC and device categories, employer benefits, and a maturing research and media layer.
The menopause economy is no longer a single product category. It now spans diagnostics, telehealth therapeutics, in-clinic care, employer benefits, and a maturing media and operator layer.
Capital and clinical guidance are catching up at the same time: virtual clinics are reaching unicorn status, the FDA has rolled back legacy estrogen warnings, and federal funding for women's-health research is increasing year over year.
Companies by infrastructure layer
Logos by layer. Click any company to open its verified profile.
At-home and clinical hormone testing making the transition legible.
Signal · Hormone testing becoming more accessible; at-home testing expanding.
Virtual clinics delivering MHT/HRT under clinician supervision.
Signal · Virtual menopause clinics achieving unicorn status; insurance coverage expanding. Midi Health press ↗
Specialty in-person and hybrid clinics standing menopause up as its own discipline.
Menopause moving onto the employer benefits roadmap alongside fertility.
Signal · Employers recognizing menopause as a workplace-health issue; dedicated benefits platforms emerging.
OTC and celebrity-led consumer brands consolidating the at-home symptom category.
Signal · Bonafide Health acquired by Pharmavite (Otsuka) for an undisclosed sum, Nov 2023 — first major strategic exit in the category. Pharmavite press release ↗
Wearables and non-pharmaceutical devices for vasomotor and continuity-of-care.
Editorial, community, and celebrity-led platforms driving cultural permission.
Societies and federal funders building the evidence base behind the category.
Signal · Federal funding for women's-health research increasing; The Menopause Society received a $10M grant from Pivotal for expanded education. NIH ORWH ↗
- 01Unicorn validation
Midi Health's $100M Series D and >$1B valuation validates the category for late-stage capital.
- 02Insurance coverage expansion
Aetna, UPMC and others now reimburse virtual menopause care; Gennev is in-network in all 50 states.
- 03Celebrity investor participation
Naomi Watts (Stripes), Judy Greer (Wile), Lena Dunham (Evernow), Gwyneth Paltrow (Goop) driving mainstream awareness.
- 04Employer adoption
Workplace menopause benefits emerging as the next category after fertility — Valerie, Evela Health, Maven.
- 05Regulatory tailwind
FDA reconsidering the legacy 'black box' warning on systemic estrogen; state-level workplace protections forming.
- 06Integrated care models
Shift from symptom management to longitudinal midlife health spanning cardio, bone, brain, and metabolic.
Companies marked “Verified source” link to a primary source (company release, SEC filing, peer-reviewed paper, or official agency page). “Press coverage” items are corroborated by reputable secondary outlets. “Source pending” items have not yet been independently re-verified at the link level.